Pharmacokinetic studies of the drugs administered to subjects with mechanical cholestasis are scarce. The purpose of the present study was to examine the effects of bile duct ligation of 3 days (peak of elevation of serum bile acids and bilirubin) on the systemic and renal PAH clearance and on the expression of cortical renal OAT1 and OAT3 in a rat model. PAH is the prototypical substrate of the renal organic anion transport system. Male Wistar rats underwent a bile duct ligation (BDL rats). Pair-fed sham-operated rats served as controls. BDL rats displayed a significantly lower systemic PAH clearance. Renal studies revealed a reduction in the renal clearance and in the excreted and secreted load of PAH in BDL rats. The OAT1 protein expression in kidney homogenates was not modified, but it decreased in the basolateral membranes from BDL rats. In contrast, OAT3 abundance in both kidney cortex homogenates and in basolateral membranes increased by 3 days after the ligation. Immunocytochemical studies (light microscopic and confocal immunofluorescence microscopic analyses) confirmed the changes in the renal expression of these transport proteins. The present study demonstrates the key role of OAT1 expression in the impaired elimination of PAH after 3 days of obstructive cholestasis.
Introduction
Extrahepatic, mechanical cholestasis occurs in about 10% of all patients suffering from cholelithiasis and in the majority of neoplasms affecting the pancreas and the common bile duct [1] . Prolonged cholestasis may alter the liver function due to an impaired uptake, changed biotransformation and secretion of compounds as well as secondary abnormalities induced within the kidney [2, 3] .
Pharmacokinetic studies of drugs administered to subjects with mechanical cholestasis are scarce [4] . Moreover, the obtained results are often conflicting, possibly due to the use of different species and interindividual differences.
The kidney and the liver play the major role in the elimination of numerous potentially toxic xenobiotics, including drugs, to-xins, and endogenous metabolites. In some cases, the loss of one route of elimination can be compensated by the other [5] . It must also be mentioned that the impairment of liver or kidney functions can cause syndromes characterized by an injury of the alternative elimination organ [6, 7] .
In human beings and rats, extrahepatic cholestasis has been shown to render the kidney susceptible to a variety of nephrotoxic agents [6] . The pathophysiological cause of renal damage in the course of bile flow impairment is still not well understood, even though several phenomena, such as increased access of various constituents into the kidney (bilirubin and bile salts) have been suggested [6, 7] .
An impairment of the kidney function produces modifications in the renal elimination of drugs mediated by alterations in the blood flow to the kidney, glomerular filtration, active tubular secretion and passive tubular reabsorption [8] .
The renal organic anion transport plays a critical role in protecting against the toxic effects of anionic substances, whether of endogenous or environmental origin, by removing such substances from the blood principally via the organic anion transporter mechanisms found in the apical and basolateral membrane of renal epithelial cells. Several carrier proteins have been cloned and are functionally characterized from both membrane domains of rat kidneys [9] [10] [11] . The organic anion transporter 1 (OAT1) and the organic anion transporter 3 (OAT3) support the exchange organic anion/dicarboxylate transport in the basolateral membranes from the proximal tubule cells [12] [13] [14] [15] . Two members of the multidrug resistance protein (MRP) family are located at the apical membranes from the proximal tubule cells, MRP2 and MRP4 [10, 11, 16, 17] . The above mentioned four proteins mediate the renal transport of several anionic substances, such as p-aminohippurate (PAH), the prototypic organic anion commonly used in experimental studies. An up-regulation of renal MRP2 has been described at 1 and 3 days after bile duct ligation [18, 19] . One day of bile duct ligation is referred as an early stage of obstructive cholestasis and 3 days of bile duct ligation is the period in which serum bile acids and bilirubin levels reach the peak of elevation [18] [19] [20] . MRP4 decreases at 3 days after bile duct ligation [21] . An increase in the urinary excretion of PAH has been concomitantly demonstrated with an increase in the abundance of OAT1 in the kidney homogenates in the early phase of an obstructive cholestasis [22] .
The purpose of the present study was thus to examine the systemic and renal PAH clearance and the role of cortical renal OAT1 and OAT3 in response to 3 days of biliary obstruction in rats.
Materials and methods

Experimental animals
Male Wistar rats aged from 110 to 130 days old were used throughout the study (380-410 g body weight). In order to perform surgical procedures the animals were anaesthetized with sulfuric ether. After an upper abdominal incision was performed under sterile condition, the common bile duct was isolated and double-ligated close to the liver hilus immediately below the bifurcation and cut between the ligatures (BDL group). The controls then underwent a sham operation that consisted of exposure, but not a ligation, of the common bile duct (Sham group). The abdominal incision was then closed by single sutures. All studies were performed 3 days after surgery. All animals were allowed free access to a standard laboratory chow and tap water, and housed in a constant temperature and humidity environment with regular light cycles (12 h) during the experiment. All animals were cared for in accordance with the principles and guidelines for the care and use of laboratory animals [23] .
Biochemical determinations
On the day of the experiment, blood was withdrawn from femoral artery of Sham and BDL animals. The serum was separated by centrifugation (3000 rpm, 3 min). These samples were used to measure total and direct bilirubin as parameters indicative of hepatic function and urea serum levels as a parameter indicative of global renal function. The above mentioned biochemical analyses were performed using optimized spectrophotometric techniques, while employing commercial kits (Wiener Laboratory).
Pharmacokinetic studies
These studies were done in a manner similar to those previously described [22, 24] . At 3 days after surgery, the animals were anaesthetized with sodium thiopental (70 mg/kg b.w., i.p.). The femoral artery and the vein were both catheterized to obtain samples and to administer test compound, respectively. A single bolus of PAH (30 mg/kg b.w., aqueous solution, i.v.) was administered.
Blood samples were obtained at 0-15 min range time after the administration of the PAH solution. The volume of blood samples was 50 μL. Eight blood samples were removed from each rat at different times between 0 and 15 min. An equivalent volume of isotonic saline solution was infused to restore the amount extracted in the blood samples. Samples were centrifuged at 3000 rpm for 3 min, and the extracted plasmas were frozen at −20°C until analyzes.
At 15 min after PAH administration, a suprapubic incision was performed in order to isolate the bladder. Both ureters and the urethra were ligated with extreme care in order not to lose any urine. Thereafter, the bladder was removed and the whole contents of urine were then obtained to measure the quantity of PAH.
The plasma concentration vs. time curves for PAH, for each individual animal, were fitted with the PKCALC computer program [25] . The data were fitted to a biexponential curve. The choice of the best fit was based on the determination of coefficient values (R 2 ) and F test [25, 26] . All fits had R 2 values >0.9. The following equation was used to describe the biexponential concentration-time curves:
where Cp is PAH plasma concentration (mg/mL) at time t (min) after administration; constant α represents the distribution from the central compartment and β is an equilibrium constant reflecting the dynamics between k 21 and K 10 
Binding of PAH to plasma proteins
The binding of PAH to plasma proteins in Sham and BDL rats was determined using an ultrafiltration apparatus (Centrifree, Amicon, Millipore Corporation, Bedford, Mass) as previously described [24] .
Renal excretion studies
These studies were performed as previously described [24, [28] [29] [30] [31] . Sham (n=4) and BDL (n=5) rats were anaesthetized as described. Femoral vein and artery were cannulated and a bladder catheter (3 mm i.d.) was inserted through a suprapubic incision. A priming dose of inulin (30 mg/kg b.w.) and PAH (30 mg/kg b.w.) in 1.5 mL of saline solution was administered through the venous catheter. Then, a solution containing inulin (12 g/L), PAH (12 g/L) and saline solution (9 g/L) was infused through the venous catheter employing a constant infusion pump (Pump 22; Harvard Apparatus, USA) at a rate of 1 mL/h/100 g b.w. After equilibrating for 45 min, urine was collected during two 20-min periods. Blood from the femoral artery was obtained at the midpoint of each clearance period. The arterial blood pressure was estimated throughout the experiments with a manometer inserted in the femoral artery. The glomerular filtration rate (GFR) was calculated from the clearance of inulin, in order to determine filtered load of PAH. The excreted, secreted and filtered loads of PAH were calculated by conventional formulae for each animal. The PAH concentrations in the serum and urine were determined by the method of Waugh and Beall [27] and the inulin concentrations were assayed by the procedure of Roe [32] . The volume of urine was determined by gravimetry.
Preparation of basolateral membrane (BLM) from kidney cortex
The preparations of BLM from Sham and BDL rats were done by a modification of the method described by Jensen and Berndt [33] as previously reported by us [24, 29] . Kidney cortical tissues were placed in a Dounce homogenizer containing 250 mM sucrose, 5 mM Tris-HEPES pH 7.40 at a ratio of 12.5 mL/g cortex wet weight. After four gentle strokes with the loose fitting pestle, the suspension was homogenized further with a motor-driven teflon pestle (600 rpm/5 strokes) and spun down for 15 min at 1200×g. The supernatant was aspirated and spun for 15 min at 22,000×g. The fluffy beige upper layer of the resulting pellet (crude plasma membranes) was resuspended in about 1 mL of supernatant and added to 19 mL of buffered sucrose. The membrane suspension was homogenized gently through a 16-gauge gavage needle followed by the addition of 3.7 mL of 100% Percoll. The Percoll-membranes mixture was spun for 30 min at 39,250×g. The top clear layer was discarded and the top-most dark band was removed. This layer was composed primarily of basolateral membranes. BLM were brought up in KCl buffer (85 mM KCl, 83 mM sucrose, 2 mM HEPES-Tris pH 7.40) at a ratio of 8 mL/g original cortex wet weight. Next, BLM were pelleted at 30,000×g for 30 min and washed three times with the KCl buffer. Finally, BLM were resuspended in 300 μL of 250 mM manitol, 10 mM HEPES-Tris, pH 7.40. Aliquots of the membranes were stored immediately at −70°C until use (no more than 2 weeks after membrane preparations). Each preparation represents cortical tissue from four animals. Four preparations were obtained for each experimental group. Protein quantification of samples was performed using the method of Sedmak and Grossberg [34] .
Electrophoresis and immunoblotting
Homogenates and basolateral membranes were boiled for 3 min in the presence of 1% 2-mercaptoethanol/2% SDS (Sodium Dodecyl Sulphate). Samples were applied to a 8.5% polyacrilamide gel, separated by SDS-PAGE, and then electroblotted to nitrocellulose membranes. Membranes were stained with Ponceau Red to confirm equal protein loading and transfer between lanes as previously described [21, 22, [28] [29] [30] . The nitrocellulose membranes were incubated with 5% nonfat dry milk in phosphate-buffer saline containing 0.1% Tween 20 (PBST) for 2 h. After being rinsed with PBST, the membranes were then incubated overnight at 4°C with a commercial rabbit polyclonal antibody against rat OAT1 (1.25 μg /mL) and with commercial mouse monoclonal antibody against human β-Actin (1.25 μg /mL) or with non-commercial rabbit polyclonal antibody against rat OAT3 (at a dilution of 1:1000) and with commercial mouse monoclonal antibody against human β -Actin (1.25 μg /mL). The specificity of OAT3 antibody has been described elsewhere [15] . The membranes were incubated for 1 h with a peroxidase coupled goat anti-rabbit IgG (Bio-Rad) or with a peroxidase coupled sheep anti mouse IgG (Amersham) after further washing with PBST. Blots were processed for detection using commercial kit (Opti-4CN, Bio-Rad for OAT1 and ECL enhanced chemiluminescence system, Amersham for OAT3). To investigate the specificity of the bands, an absorption test was performed. The OAT1 peptide (1.25 μg /mL) or OAT3 peptide (0.50 mg /mL) were added to the OAT1-antibody specific solution or OAT3-antibody specific solution respectively and incubated for 2 h. Using these preabsorbed antibodies, Western blot analyses were performed as described above. A densitometric quantification of the Western blot signal intensity of membranes was performed. 
Immunocytochemistry microscopy
Kidneys from Sham and BDL rats were briefly perfused with saline, followed by perfusion with periodate-lysine-paraformaldehyde solution (0.01 M NaIO 4 , 0.075 M lysine, 0.0375 M phosphate buffer, with 2% paraformaldehyde, pH: 6.20), through an abdominal cannula. The kidneys slices were immersed in periodate-lysine-paraformaldehyde solution at 4°C overnight. The tissue was embedded in paraffin. Paraffin sections were cut. After deparaffining, the sections were incubated with 3% H 2 O 2 for 15 min (to eliminate endogenous peroxidase activity) and then with blocking serum for 30 min. The sections were then incubated with non-commercial polyclonal antibodies against OAT1 (diluted 1:1000) or OAT3 (diluted 1:1000) overnight at 4°C. The specificity of both antibodies has been described elsewhere [15] . The sections were rinsed with PBST.
Light microscopic analysis
The sections were incubated with biotinylated secondary antibody against rabbit Immunoglobulin for 1 h (biotinylated Ig Multi-Link Biogenex). After being rinsed with PBST, the sections were incubated for 30 min with horseradish peroxidase (HRP)-conjugated streptavidin solution (Streptavidin/HRP complex Multi-Link Biogenex). In order to detect HRP labeling a peroxidase substrate solution with diaminobenzidine (0.05% diaminobenzidine in PBST with 0.05% H 2 O 2 ) was used. The sections were counterstained with hematoxylin before being examined under a light microscope.
Confocal microscopic analysis
The sections were incubated with Alexa 488 fluorochrome-conjugated goat anti-rabbit IgG, 1:1000 (Molecular Probes, Eugene, OR) overnight at 4°C.
Sections were washed with PBST and then mounted. Afterwards, they were viewed on a Zeiss Axiophot microscope equipped with an epifluorescence detector and a Bio-Rad MRC 1260 confocal imaging system. Controls using preimmune serum, antiserum absorbed with excess synthetic peptide (as described above), or omission of primary or secondary antibody revealed no labeling. 
Histopathological studies
Histopathology of kidneys was performed after fixing in 10% neutral buffered formaldehyde solution for 4 h and embedding in paraffin, then 4 μm thick sections were processed for routine staining with hematoxylin and eosin, or stained with hematoxilin and PAS.
Materials
Chemicals were purchased from Sigma (St. Louis, MO, USA) and were analytical grade pure. The polyclonal antibodies against OAT1, monoclonal antibodies against β-actin and the OAT1 peptide for Western blotting were purchased from Alpha Diagnostic International (San Antonio, TX, USA). The polyclonal antibody against OAT1 for immunocytochemical studies and polyclonal antibody against OAT3 and the OAT3 peptide for both Western and immunocytochemical studies were non-commercial [15] .
Statistical analysis
The statistical analysis was performed using the unpaired t-test. When variances were not homogeneous a Welch's correction was employed. P values of less than 0.05 were considered significant. The values are expressed as the means ± standard error (SEM). For these analyses, a GraphPad software was used. For densitometry of immunoblots, samples from kidneys of BDL rats were run on each gel with corresponding Sham kidneys. The abundance of OAT1 and OAT3 in the samples from the experimental animals was calculated as percentage of the mean Sham control value for that gel.
Results
Total bilirubin concentration in BDL rats increased to 71.34 ± 4.31 mg/L from 2.51 ± 0.36 mg/L observed in Sham group, whereas direct bilirubin level increased from 1.30± 0.24 mg/L in Sham animals to 66.85± 4.16 mg/L in BDL ones. Light microscopy only showed significant renal morphological alterations in PAS stained kidneys. In BDL rats, the kidney appears congestive, predominantly in the medulla. The tubular epithelium is less tall and shows apical extrusions and its foldings are less conspicuous. The cytoplasm presents a PAS (+) granularity. The tubules are moderately dilated, containing intraluminal proteinaceous, eosinophilic and acidophylic, material. These results are similar to those described by Wójcicki et al. [4] .
On the other hand, no significant difference in the urea serum levels (g/L) was observed between the Sham-operated and BDL animals (0.40 ± 0.02 vs. 0.41 ± 0.02 respectively).
The mean plasma concentration-time profiles for PAH in Sham and BDL rats are shown in Fig. 1A . The higher plasma concentrations of PAH in BDL group were displayed during the distribution and elimination phases. BDL rats displayed a significant higher area under the curve and therefore a significant lower systemic clearance for PAH (Fig. 1B) . The constant α (which represents the distribution from the central compartment), the constant β (which is an equilibrium constant reflecting the dynamics between k 21 and K 10 ), the rate constants of transfer from central to peripheral compartments (k 12 , k 21 ) and the elimination rate constant from the central compartment (K 10 ) were all decreased in BDL rats, thus indicating the impairment in the rates of distribution and elimination of PAH (see Table 1 ). The distribution volumes were not significantly different between the Sham-operated and BDL animals as it is shown in Table 1 .
A statistically significant decrease was observed in the quantity of PAH excreted in urine during 15 min (Fig. 2) .
The percentage of unbound PAH to plasma proteins was higher in BDL rats than in the Sham ones (100 ± 0.1 (n = 4) vs. 95.3 ± 1.4 (n = 4), P < 0.05, respectively). The values obtained for the Sham rats are similar to those previously reported [24] .
Renal studies showed a decrease in the renal clearance of PAH in BDL rats as it is shown in Fig. 3 . The excreted, secreted and filtered loads of PAH were lower in BDL rats compared with Sham rats, even though for the filtered load of PAH the difference did not reach the level of significance ( Table 2 ). The glomerular filtration rate from jaundiced group was significantly lower in comparison with Sham group as it is also shown in Table 2 . As a result, excreted load of PAH was lower in the BDL rats as consequence of the decrease in the secreted load of this organic anion.
Kidney cortex homogenates and basolateral membranes from Sham and BDL animals were subjected to immunoblot analyses for OAT1 protein. Fig. 4 shows no difference between the groups in the homogenates OAT1 expression. On the other hand, a lower abundance of OAT1 was observed in the basolateral membranes from BDL rats in comparison to the Sham rats. The OAT1 protein disappeared when the antibody was preabsorbed to the synthetic antigen peptide (data not shown).
Immunocytochemistry using horseradish peroxidase-conjugated secondary antibodies for light microscopy confirmed the reduced OAT1 expression in basolateral plasma membranes from BDL rats (Fig. 5B ). The Sham rats showed an abundant OAT1 labeling in basolateral domains (Fig. 5A) . To further characterize the distribution of OAT1 labeling in the proximal tubule cells, immunofluorescence was used ( Fig. 5C and D) . Confocal immunofluorescence studies also revealed a decrease in OAT1 labeling in basolateral plasma membranes and allowed a better appreciation of a punctuate labeling for OAT1, which was distributed widely throughout the cytoplasm in the kidneys from the BDL rats demonstrating the cellular internalization of this carrier protein.
The Western blotting findings of the kidney cortex homogenates and BLM from Sham and BDL rats showed signals for OAT3. In Fig. 6 it is possible to observe that the OAT3 abundance significantly increased in the kidney cortex homogenates and in the BLM from BDL rats in comparison to Sham ones. These signals were not observed when the antibody was preabsorbed with the OAT3 peptide (data not shown).
Immunocytochemistry studies showed staining for OAT3 in many parts of the nephron such as the proximal tubule (S1, S2 and S3), the distal and the collecting duct as it has been previously described [15] . Sham rats showed OAT3 labeling in basolateral membrane domain and inside the cytoplasm of renal tubular cells (Fig. 7A) . Increased labeling was seen in the basolateral membranes of the tubules from kidneys of BDL rats (Fig. 7B) . Immunofluorescence microscopy showed the basolateral membrane localization of OAT3 and a better detection of the intracellular localization (Fig. 7C ). An important increase of OAT3 in basolateral membranes was observed in the cortex from Fig. 6 . Renal homogenates (50 μg proteins) (A) and basolateral membranes (40 μg proteins) (C) from kidneys of Sham and BDL rats were separated by sodium docecyl sulphate-polyacrylamide gel electrophoresis (8.5%) and blotted onto nitrocellulose membranes. OAT3 was identified using non-commercial polyclonal antibodies as described in Materials and methods. The densitometric quantification of the OAT3 Western immunoblotting from renal homogenates (B) and basolateral membranes (D). Results are expressed as percentage, normalized for the β actin density. The Sham levels were set at 100%. Each column represents the mean ± SEM from experiments carried out in four different membrane preparations for each experimental group. # P < 0.05. kidneys of BDL rats (Fig. 7D ). This pattern parallels the data from an immunoblotting study.
Discussion
A large and diverse number of organic anions, or weak organic acids that exist as anions at physiological pH, are secreted by mammalian renal tubules. Substrates for the renal organic anion transport system include weak acids that have a net negative charge on carboxyl or sulfonyl residues at physiological pH [9] [10] [11] . Although this system secretes a number of endogenous compounds, it is generally accepted that is particularly important in secreting numerous exogenous compounds, including pharmacologically active substances, industrial and environmental toxins, and plant and animal toxins [9] [10] [11] . The transport of these substances across the basolateral membrane of renal epithelial cells is energetically uphill [9] [10] [11] . Molecular candidates for each of the organic anion transport process have been cloned, including OAT1 and OAT3 that serve as organic anion/dicarboxylate exchangers at the basolateral membrane of renal proximal tubule cells [9] [10] [11] [12] [13] [14] [15] . An unexplored aspect of OATs regulation concerns the body's response to disease states. We have recently demonstrated alterations in renal OAT1 and OAT3 expression in different experimental models in rats such as bilateral ureteral obstruction [28, 29] , arterial calcinosis [31] , and chronic renal failure [30] . However, little is known about the regulation of these transporters after the early phase of extrahepatic cholestasis.
Acute jaundice due to bile duct obstruction is defined as the retention of bile and bile components. Biliary excretion of organic anions is a critical physiologic function of the liver. However, in obstructive jaundice, in which the biliary transport is impaired, adaptive mechanisms involving protein expression may permit urinary excretion of those potentially toxic compounds [1, 4] . There are limited data on the pharmacokinetics of drugs in subjects with biliary obstruction.
Performing bile duct ligation as a well-established model of cholestasis, we have determined an increase in the systemic clearance of PAH associated to an increase in the abundance of OAT1 in renal cortex homogenates in rats at 21 h after bile duct ligation (early phase of acute extrahepatic cholestasis) [22] . The . Serial sections from each rat kidney were stained using a non-commercial anti-rOAT3 antibody. OAT3 labeling was seen at the basolateral domains of tubule cells and inside the cells. In BDL rats, it can be seen an increased OAT3 labeling in BLM. These figures are representative of typical samples from four rats. Magnification ×400. (C and D) Immunofluorescence localization of OAT3 in the renal cortex of the Sham (C) and BDL rats (D). Serial sections from each rat kidney were stained using a non-commercial anti-rOAT3 antibody. OAT3 labeling was seen at the basolateral domains of tubule cells and inside the cells. In the BDL rats, it could be seen as an increased OAT3 labeling in the BLM of tubular cells. These figures are representative of typical samples from four rats. Magnification ×400.
aim of the present study was to examine the systemic and the renal clearance of PAH and the expression of both OAT1 and OAT3 in homogenates and basolateral membranes from rat renal cortex after a period of 3 days of bile duct obstruction (it has been well documented that serum bile salts and bilirubin levels reach the peak of elevation after 3 days of ligation [18] [19] [20] ).
The clearance of a drug may be defined in a general way as "a proportionality constant describing the relationship between a substance's rate of transfer, in amount per unit time, and its concentration, in an appropriate reference fluid" [35] . The current study shows that rats at 3 days after bile duct ligation exhibit an increase in the area under the PAH plasma concentration-time curve and therefore, a statistically different decrease in the total body clearance. Furthermore, the total body clearance can be expressed as the product of the elimination rate microconstant (K 1-0 ) from the central compartment and the volume of such compartment. This last parameter was not modified in rats with extrahepatic cholestasis. On the other hand, a decrease was observed in K 1-0 in bile duct ligated rats as compared with Sham ones. K 1-0 is influenced by variables that participate in the elimination of the drug from the central compartment, such as metabolization, renal and biliary excretion. As PAH metabolization and biliary excretion is negligible, the decrease of K 1-0 observed in treated animals indicates a lower renal elimination of this organic anion. In this connection, rats subjected to bile duct ligation for 3 days showed a diminished renal PAH clearance. The decrease in renal PAH elimination is accounted for the diminished secreted load of the drug, since the filtered load of PAH was not modified in the BDL group.
In this cholestatic model, the OAT1 expression significantly decreased in the basolateral membranes from kidneys after 3 days of bile duct ligation. In addition to immunoblotting, immunocytochemical techniques corroborates the decrease in the basolateral membranes expression of OAT1 together with a significantly enhanced immunocytochemical staining for OAT1 in the cytoplasm of proximal tubule cells of BDL kidneys, which might suggest an internalization of membrane transporters or an inhibition in the recruitment of preformed transporters into the membranes.
It has been demonstrated that OAT1, when heterologously expressed in oocytes or mammalian cells, is inhibited by more or less selective PKC activators [36, 37] . In this connection, it was demonstrated by Wolff et al. [38] that PKC induces human OAT1 down-regulation through carrier retrieval from the cell membrane and it does not involve phosphorylation. It is well known that angiotensin II [39] modulates the renal proximal tubule function via activation of PKC. Although the role of the renin-angiotensin system in the BDL model remains controversial [7] , some humoral factors including angiotensin II induced by the 3 days BDL may induce the activation of PKC. Moreover, bile acids and high bilirubin levels can activate PKC [40, 41] . It has been demonstrated that 3 days of bile duct ligation is the period in which serum bile acids and bilirubin levels reach the peak of elevation. We therefore postulate that the peak of elevation of bile acids and bilirubin can also trigger PKC activation. This PKC activation may cause the phosphorylation of caveolin-2, which may induce internalization of caveolae with OAT1 protein anchored with caveolin as has been recently suggested by Kwak et. al. [42] . This OAT1 downregulation (30%) was associated with a concomitant decrease of renal and systemic PAH clearance (40% and 30% respectively). The medium PAH plasma concentrations reached during the renal clearance infusion studies were 295 μM and 376 μM for the Sham and BDL rats respectively. The OAT1 mediated uptake of PAH is saturable with apparent Michaelis constants ranging 15 to 70 μM for rat OAT1 [13] . Therefore, PAH concentrations that we obtained in our "in vivo" experiments were sufficiently higher than the reported Km of rat OAT1. The diminished secreted load of PAH measured under saturating conditions was in part account for the lower number of OAT1 protein units observed, by immunoblot technique, in basolateral plasma membranes from BDL kidneys. The opposite was observed in the early phase of extrahepatic cholestasis where an increase of 30% of OAT1 abundance was associated with a similar increase in PAH clearance [22] . The differences observed in OAT1 abundance between 21 and 72 h of bile duct ligation remain to be explained. The increased OAT1 abundance observed in the early phase of extrahepatic cholestasis suggests a transient up-regulation similar to those described for renal OCT1 in cholestatic rats [43] . Maybe, different levels of various cytokines and growth factors which may affect gene transcription might be involved [44] .
In contrast with OAT1, OAT3 expression increased both in homogenates and BLM from BDL kidneys. OAT3 is found in various cells and in all parts of the nephron, whereas OAT1 is confined to proximal tubules. The human and rat OAT3 transport PAH with relatively high affinity (87 and 65 μM respectively) [14, 45] , similarly to OAT1. On the contrary, estrone sulfate, cholate, and taurocholate are substrates for OAT3 and not for OAT1 as it has been demonstrated using Xenopus laevis oocytes [12, 14, 45, 46] , MDCK cells [47] and OAT3 knockout mice [48] . It is therefore possible that the over-expression of OAT3 does not compensate for the down-regulation of OAT1 regarding PAH transport because in this pathology the high plasma levels of bile acids might compete with PAH for OAT3 transport. Moreover, bile acids have been shown to regulate the expression of several genes involved in bile salt transport [49] [50] [51] . It is possible that high bile acids levels up-regulate OAT3 expression without affecting the OAT1 expression, being this another example of substrate specific regulation. The up-regulation of OAT3 protein in rat kidney in the present study is thus consistent with the adaptation to increased plasma bile acid levels that result from obstructive cholestasis, thus providing an additional alternative pathway for bile salt elimination.
MRP2 up-regulation has been described in the kidneys from rats with bile duct obstruction of 1 and 3 days [18, 19] . On the other hand, renal MRP4 was down-regulated at 3 days after biliary obstruction [21] . Therefore, the protein expression of the luminal (MRP2 and MRP4) and basolateral organic anions renal transporters (OAT1 and OAT3), which all transport PAH, are differently regulated in extrahepatic biliary obstruction, thus indicating that different roles are played by these transporters in the pathogenesis of cholestasis. Tubular secretion is a vectorial transcellular transport system consisting of basolateral entry into the epithelial cells and secretion across the brush border membranes. Defects in either of these two processes should therefore influence the tubular secretion of ionic drugs. In the present study, the tubular secretion of PAH was markedly reduced, thus suggesting a predominant role of OAT1 in this process.
It is important to mention that to predict the efficacy of a drug in vivo, it is critical to account for plasma protein binding because it determines the availability of the free drug, its halflife, and its subsequent renal elimination. Bow et al. [52] recently demonstrated that the degree of binding affinity for albumin to substrate determines whether or not a compound is actively secreted or reabsorbed by organic anion transporters. The common high unbound fraction of PAH increased from 95% in Sham rats to 100% in BDL rats. Since the bile acids and bilirubin plasma levels significantly increased in this experimental model, hence the binding sites on albumin for such hydrophobic anions might thus be occupied in the jaundiced rat, thereby increasing even more the unbound fraction of PAH.
The increase in the unbound fraction of PAH in BDL rats did not modify the distribution volumes of this anion. Nevertheless, in BDL rats there is a higher free concentration of PAH available for organic anion transporters, the OAT1 downregulation leads to a decrease in renal and systemic PAH clearance, thereby again stressing the main role of OAT1 in PAH excretion.
The present study stresses, once more, the important role of OAT1 expression in the renal elimination of PAH, independently of renal OAT3 expression. In this connection, it has been reported that a decrease of OAT1 abundance in BLM is associated with a decrease in PAH renal elimination in chronic renal failure [30] , in obstructive nephropathy [28, 29] and in response to 3 days of bile duct ligation, as it is shown in the present study. Meanwhile, OAT3 abundance in renal BLM has not changed, decreased or increased, respectively, in these three experimental models of pathologies [28] [29] [30] . Moreover, the increased renal excretion of PAH and furosemide is concomitantly observed with an increase in OAT1 and no changes in OAT3 abundance in BLM from rats with an early stage of extrahepatic cholestasis [22, 53] . Accordingly, Eraly et al. [54] recently reported, using the OAT1 knock out mouse model, that regardless of the potential contribution of OAT3, the bulk of organic anion transport during the basolateral uptake step of the classical pathway is mediated by OAT1.
As highly accumulated anionic drugs observed during cholestasis may cause general body deterioration, the molecular mechanism(s) involved in the differential renal regulation of MRP2, MRP4, OAT3 and OAT1 expression should therefore be elucidated to prevent the occurrence of drug-induced toxicity due to this pathology.
